Sir Philip Cohen ranked second of the 561,800 biologists and biochemists who published research papers over the ten years between 1992 and 2002. During this period, his research papers were cited 14,186 times, according to the Philadelphia based Inst …more
News
The MRC PPU have announced the renewal of their major collaboration with the pharmaceutical industry.
Agreement has been reached with six of the world's major pharmaceutical companies (AstraZeneca, Boehringer Ingelheim International GmbH, …more
Agreement has been reached with six of the world's major pharmaceutical companies (AstraZeneca, Boehringer Ingelheim International GmbH, …more

Sheelagh Frame, a Postdoctoral Researcher who worked in both the DSTT and the MRC Unit, left the Unit on the 29th March 2002 after spending 3 years here. Sheelagh has decided to re-enter the biotechnology sector (having worked in Onyx Pharmaceuticals …more
A brand-new laboratory complex has just been opened next to the Division of Signal Transduction Therapy (DSTT) on the first floor of the MSI-WTB Complex. The laboratory houses the research group of Professor Tricia Cohen and is shared with that of Dr …more

Calum Sutherland, a Wellcome Career Development Fellow who has been running his research group within the MRC Unit over the past 5 years, has been appointed to a Lectureship in the Department of Pharmacology at the University of Dundee's Medical Scho …more

Philip Cohen gave the 7th annual Lehninger Lecture at Johns Hopkins University, Baltimore on March 12th 2002. Held in honour of one of the world's most famous bioenergeticists, Albert Lehninger (1917-1986) is most widely known for writing the first r …more

Dario Alessi, Programme Leader in the MRC Protein Phosphorylation Unit has been awarded the Royal Society of Edinburgh's Makdougall Brisbane prize for his discovery and characterisation of PDK1, the "missing link" in insulin signal transduction.
…more
…more

Axel Knebel who, until recently, was a Postdoctoral Fellow in Philip Cohen's group, has set up a new company called Kinasource, which aims to exploit commercially the new method for identifying substrates of protein kinases (termed KESTREL, EMBO Vol …more

Alfonso Mora, working in the group of Dario Alessi in the Unit, has been awarded a prestigious Postdoctoral Fellowship by the Spanish Ministry for Culture and Sport. This Fellowship will fund Alfonso's work for two years to work on conditional PDK1 k …more
For the second consecutive year we have successfully secured one of the new highly prestigious Predoctoral Fellowships offered by the Medical Research Council (MRC). David Komander will join the groups of Daan van Aalten and Dario Alessi in June 2002 …more